Track Poly Medicure Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 0.73 %
Low
1,622.5
High
1,776.7
1 Month returns: 9.29 %
Low
1,526.3
High
1,777.0
1 Year returns: -21.28 %
Low
1,182.0
High
2,144.9
3 Year CAGR: 15.11 %
Low
1,091.3
High
3,357.8
5 Year CAGR: 11.89 %
Low
651.1
High
3,357.8
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Poly Medicure Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Poly Medicure Ltd. Shareholding Pattern
Quarterly breakdown of Poly Medicure Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Poly Medicure Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Poly Medicure Ltd.?
The current share price of Poly Medicure Ltd. is ₹ 1,680.50 as of 17 Jul 2026.
What is the market capitalisation of Poly Medicure Ltd.?
The market capitalisation of Poly Medicure Ltd. stands at ₹ 17,033.40 Cr.
What is the PE ratio of Poly Medicure Ltd.?
The Price-to-Earnings (PE) ratio of Poly Medicure Ltd. is 52.88 as of the latest trailing twelve months data.
What is the ROE and ROCE of Poly Medicure Ltd.?
Poly Medicure Ltd. has a Return on Equity (ROE) of 10.96% and a Return on Capital Employed (ROCE) of 10.13% as per the latest financial reports.
What is the 52-week high and low of Poly Medicure Ltd.?
The 52-week high of Poly Medicure Ltd. is - and the 52-week low is -.
What is the dividend yield of Poly Medicure Ltd.?
The dividend yield of Poly Medicure Ltd. is 0.21% based on the current market price.
What is the FII and DII holding in Poly Medicure Ltd.?
Foreign Institutional Investors (FII) hold 5.92%, Domestic Institutional Investors (DII) hold 12.18% and retail/public investors hold 13.57% of Poly Medicure Ltd. shares.
What sector does Poly Medicure Ltd. belong to?
Poly Medicure Ltd. operates in the Healthcare sector. 40% of analysts have a Buy or Strong Buy rating on Poly Medicure Ltd. with a consensus target price of ₹ 1,650.00, implying 1.81% downside from current levels.
What is the beta of Poly Medicure Ltd.?
The beta of Poly Medicure Ltd. is 0.87, indicating its price volatility relative to the broader market. Over the past 1 year, Poly Medicure Ltd. has delivered an absolute return of -24.64%.
What is the RSI of Poly Medicure Ltd.?
The 14-day Relative Strength Index (RSI) of Poly Medicure Ltd. is 56.49, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Holdings and Presence
Indices and prominent investors with a stake in this stock.
Fundamental analysis overview of Poly Medicure Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Low Debt to Equity, not much change from last year
The company has low Debt to Equity of 0.11 as on 31 Mar 2026 and Debt to Equity increased marginally by 0.04 in the last 1 year
What is Debt to Equity?
Consistently pays dividend
The company has not missed dividend payments once in the last 5 financial years
What is Dividend streak?
Company is net cash
The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet
What is Net Debt ?
Negative
Expensive and at a premium to industry median P/E
PE TTM of 52.88 indicates that the stock is expensive on a standalone basis and is at a 70.09% premium to industry median P/E
What is P/E Ratio?
Median: 31.09
Value 52.88
7.19128.23
Analysts have been downgrading forward EPS estimates
Analyst EPS estimate (consensus) for forward EPS has decreased by -0.04% in the last 3 months, indicating weak earnings momentum
What is Earnings upgrade (3M)?
Moderate ROE but declining trend
The company reported moderate ROE of 10.96% for 12-month ended 31 Mar 2026 but ROE declined by -500 bps from 1 year ago
What is ROE (FY)?
Low dividend yield
The company has a low dividend yield of 0.21%
What is Dividend yield?
Neutral
High operating margin but declining trend
The company reported strong operating margin of 17.43% for 12-month ended 31 Mar 2026 but operating margin declined by -473 bps from 1 year ago
What is Operating profit margin?
Moderate revenue growth and in line with median growth of industry
The company delivered moderate revenue growth of 12.56% for 12-month ended 31 Mar 2026 and the growth was 1.37 percentage points lower than median growth of industry
What is Sales growth (1Y)?
Median: 13.93
Value 12.56
-59.37118.18
Low EPS growth but above median growth of industry
The company delivered low EPS growth of -6.93% for 12-month ended 31 Mar 2026 but the growth was 10.19 percentage points higher than median growth of industry
What is EPS growth (1Y)?
Company's earnings are of moderate quality
Earnings quality score of 52.1 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
52.1 / 100
No red flags found!
No significant red flags found in the stock.
Name
Month
Transaction
Holding % pre transaction
Average price
Qty.
Transaction value
RISHI BAID
Promoter & Director
August-2023
Market Sale (Disposal)
17th Aug 2023
10.21 %
₹ 1,473.92
24.95 k
₹ 3.68 cr
RISHI BAID
Promoter & Director
August-2023
Market Sale (Disposal)
14th Aug 2023
10.31 %
₹ 1,472.70
99.26 k
₹ 14.62 cr
RISHI BAID
Director
April-2022
Market Sale (Disposal)
1st Apr 2022
10.35 %
₹ 943.63
30.00 k
₹ 2.83 cr
RISHI BAID
Director
March-2022
Market Sale (Disposal)
29th Mar 2022
10.41 %
₹ 847.67
60.00 k
₹ 5.09 cr
RISHI BAID
Director
March-2022
Market Sale (Disposal)
28th Mar 2022
10.42 %
₹ 846.94
10.00 k
₹ 84.69 lac
VCB TRADING LLP
Promoter Group
July-2021
Market Sale (Disposal)
1st Jul 2021
3.80 %
₹ 995.00
1.00 lac
₹ 9.95 cr
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Company Profile
Overview of Poly Medicure Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Poly Medicure Limited is an India-based medical device manufacturer and exporter, with its products sold in over 125 countries. The Company is primarily in the business of manufacturing and selling medical devices. With a portfolio of over 200 medical devices and more than 330 patents, the Company offers a comprehensive range of medical devices across 12 medical therapies, including infusion therapy, vascular access, dialysis and renal care, critical care, cardiology, oncology, transfusion, diagnostics, gastroenterology, anesthesia and respiratory care, urology, and surgery and wound management. Its products consist of an I.V. cannula, arterial cannula, prefilled syringe, nasogastric feeding tube, gastro-duodenal feeding tube, umbilical catheter, irrigation sets, urine drainage catheters and others.
Poly Medicure Limited is an India-based medical device manufacturer and exporter, with its products sold in over 125 countries. The Company is primarily in the business of manufacturing and selling medical devices. With a portfolio of over 200 medical devices and more than 330 patents, the Company o...
Key personnel
Shri. Naresh Vijayvargiya
Chief Financial Officer
Shri. Avinash Chandra
Compliance Officer, Company Secretary
Shri. Ravi Prakash
Deputy Company Secretary
Mr. Devendra Raj MehtaD
Non-Executive and Non-Independent Chairman of the Board